We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$202M
AUM Growth
+$585K
Cap. Flow
-$6.9M
Cap. Flow %
-3.41%
Top 10 Hldgs %
46.14%
Holding
97
New
4
Increased
11
Reduced
63
Closed
2

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$210K
2
BX icon
Blackstone
BX
+$152K
3
DHR icon
Danaher
DHR
+$126K
4
PFE icon
Pfizer
PFE
+$57.9K
5
FFIV icon
F5
FFIV
+$57.8K

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$904K
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$735K
3
AAPL icon
Apple
AAPL
+$666K
4
GS icon
Goldman Sachs
GS
+$493K
5
ZTS icon
Zoetis
ZTS
+$365K

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Financials 19.59%
3 Industrials 18.05%
4 Healthcare 15.45%
5 Communication Services 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$18.2M 8.99%
66,911
-2,482
-4% -$666K
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.36T
$16.4M 8.11%
52,302
-2,564
-5% -$735K
GS icon
3
Goldman Sachs
GS
$300B
$13.2M 6.53%
15,029
-604
-4% -$493K
TEL icon
4
TE Connectivity
TEL
$59.6B
$7.94M 3.92%
34,898
-1,115
-3% -$258K
BN icon
5
Brookfield
BN
$104B
$7.75M 3.83%
168,986
-3,864
-2% -$176K
CM icon
6
Canadian Imperial Bank of Commerce
CM
$108B
$7.31M 3.61%
80,660
-1,180
-1% -$101K
BA icon
7
Boeing
BA
$171B
$6.13M 3.03%
28,251
-20
-0.1% -$4.11K
HSY icon
8
Hershey
HSY
$35.2B
$5.65M 2.79%
31,023
-670
-2% -$122K
SNA icon
9
Snap-on
SNA
$21.2B
$5.54M 2.74%
16,080
-145
-0.9% -$49.6K
TMO icon
10
Thermo Fisher Scientific
TMO
$213B
$5.27M 2.6%
9,100
-154
-2% -$87.1K
DHR icon
11
Danaher
DHR
$137B
$4.95M 2.45%
21,641
+573
+3% +$126K
RTX icon
12
RTX Corp
RTX
$290B
$4.9M 2.42%
26,709
-240
-0.9% -$41.7K
ABBV icon
13
AbbVie
ABBV
$443B
$4.39M 2.17%
19,205
-595
-3% -$136K
EMR icon
14
Emerson Electric
EMR
$83.9B
$4.27M 2.11%
32,155
-500
-2% -$66.3K
YUM icon
15
Yum! Brands
YUM
$41.8B
$4.18M 2.06%
27,607
-365
-1% -$54.1K
MS icon
16
Morgan Stanley
MS
$331B
$3.71M 1.83%
20,923
-1,831
-8% -$305K
JKHY icon
17
Jack Henry & Associates
JKHY
$10.9B
$3.71M 1.83%
20,350
-365
-2% -$60.8K
DE icon
18
Deere & Co
DE
$160B
$3.43M 1.69%
7,363
-55
-0.7% -$25.8K
BWA icon
19
BorgWarner
BWA
$13.1B
$3.37M 1.67%
74,870
-2,385
-3% -$104K
INTC icon
20
Intel
INTC
$455B
$3.37M 1.66%
91,333
MAS icon
21
Masco
MAS
$14.1B
$3.23M 1.59%
50,825
-1,385
-3% -$89.9K
ETN icon
22
Eaton
ETN
$161B
$2.98M 1.47%
9,370
-30
-0.3% -$10.6K
TRP icon
23
TC Energy
TRP
$70.2B
$2.81M 1.39%
51,172
-1,195
-2% -$63.8K
MOS icon
24
The Mosaic Company
MOS
$7.03B
$2.77M 1.37%
115,145
-3,965
-3% -$107K
MSFT icon
25
Microsoft
MSFT
$3.45T
$2.77M 1.37%
5,721
-147
-3% -$73.7K

Similar funds

Lipe & Dalton's Q4 2025 Portfolio in Review

As of Q4 2025, Lipe & Dalton held 97 positions worth $202M, up 0.29% from $202M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lipe & Dalton withdrew a net $6.9M in Q4 2025, closing 2 positions and reducing 63 holdings. Its most notable exit was Fiserv Inc, an estimated $904K position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.

Against the trend, Lipe & Dalton opened a new position in Regeneron Pharmaceuticals worth $239K.

  • Lipe & Dalton's largest Q4 2025 buy was Regeneron Pharmaceuticals: 309 shares worth $239K.
  • Lipe & Dalton added most to Danaher in Q4 2025, an estimated $126K increase.
  • Lipe & Dalton's biggest Q4 2025 reduction was Alphabet (Google) Class C, cutting an estimated $735K.
  • Lipe & Dalton fully exited Fiserv Inc in Q4 2025, selling an estimated $904K.
  • Lipe & Dalton's ten largest holdings make up 46% of its $202M portfolio in Q4 2025.
  • Lipe & Dalton opened 4 new positions and closed 2 in Q4 2025.
  • Lipe & Dalton's portfolio value rose 0.29% quarter-over-quarter to $202M.

Based on Lipe & Dalton's 13F filing for Q4 2025, filed 26 Jan 2026.